Clinical Trial Update: Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether adding vitamin D to pegylated interferon and ribavirin improves efficacy in chronic hepatitis C patients who did not respond to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• Vitamin D (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED